메뉴 건너뛰기




Volumn 73, Issue 6, 2018, Pages 1525-1529

In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment

Author keywords

[No Author keywords available]

Indexed keywords

AVIBACTAM PLUS CEFTAZIDIME; CARBAPENEM; COLISTIN; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; ANTIINFECTIVE AGENT; AVIBACTAM, CEFTAZIDIME DRUG COMBINATION; AZABICYCLO DERIVATIVE; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE; CEFTAZIDIME; PORIN;

EID: 85048120125     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dky082     Document Type: Article
Times cited : (131)

References (20)
  • 1
    • 84942240891 scopus 로고    scopus 로고
    • Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance
    • Pitout JD, Nordmann P, Poirel L. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 2015; 59: 5873-84
    • (2015) Antimicrob Agents Chemother , vol.59 , pp. 5873-5884
    • Pitout, J.D.1    Nordmann, P.2    Poirel, L.3
  • 2
  • 3
    • 85011085656 scopus 로고    scopus 로고
    • Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms
    • Temkin E, Torre-Cisneros J, Beovic B et al. Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms. Antimicrob Agents Chemother 2017; 61: e01964-16
    • (2017) Antimicrob Agents Chemother , vol.61
    • Temkin, E.1    Torre-Cisneros, J.2    Beovic, B.3
  • 4
    • 84995524184 scopus 로고    scopus 로고
    • Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections
    • Shields RK, Potoski BA, Haidar G et al. Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections. Clin Infect Dis 2016; 63: 1615-8
    • (2016) Clin Infect Dis , vol.63 , pp. 1615-1618
    • Shields, R.K.1    Potoski, B.A.2    Haidar, G.3
  • 5
    • 85018158691 scopus 로고    scopus 로고
    • Mutations in blaKPC-3 that confer ceftazidime-avibactam resistance encode novel KPC-3 variants that function as extended-spectrum b-lactamases
    • Haidar G, Clancy CJ, Shields RK et al. Mutations in blaKPC-3 that confer ceftazidime-avibactam resistance encode novel KPC-3 variants that function as extended-spectrum b-lactamases. Antimicrob Agents Chemother 2017; 61: e02534-16
    • (2017) Antimicrob Agents Chemother , vol.61
    • Haidar, G.1    Clancy, C.J.2    Shields, R.K.3
  • 6
    • 85014206835 scopus 로고    scopus 로고
    • Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of carbapenem-resistant Klebsiella pneumoniae infections
    • Shields RK, Chen L, Cheng S et al. Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of carbapenem-resistant Klebsiella pneumoniae infections. Antimicrob Agents Chemother 2017; 61: e02097-16
    • (2017) Antimicrob Agents Chemother , vol.61
    • Shields, R.K.1    Chen, L.2    Cheng, S.3
  • 7
    • 85021816193 scopus 로고    scopus 로고
    • High ceftazidime hydrolysis activity and porin OmpK35 deficiency contribute to the decreased susceptibility to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae
    • Shen Z, Ding B, Ye M et al. High ceftazidime hydrolysis activity and porin OmpK35 deficiency contribute to the decreased susceptibility to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae. J Antimicrob Chemother 2017; 72: 1930-6
    • (2017) J Antimicrob Chemother , vol.72 , pp. 1930-1936
    • Shen, Z.1    Ding, B.2    Ye, M.3
  • 8
    • 85019677848 scopus 로고    scopus 로고
    • Resistance to ceftazidime-avibactam in Klebsiella pneumoniae due to porin mutations and the increased expression of KPC-3
    • Humphries RM, Hemarajata P. Resistance to ceftazidime-avibactam in Klebsiella pneumoniae due to porin mutations and the increased expression of KPC-3. Antimicrob Agents Chemother 2017; 61: e00537-17
    • (2017) Antimicrob Agents Chemother , vol.61
    • Humphries, R.M.1    Hemarajata, P.2
  • 10
    • 84878275967 scopus 로고    scopus 로고
    • Evaluation of phenotypic and genotypic approaches for the detection of class A and class B carbapenemases in Enterobacteriaceae
    • Ambretti S, Gaibani P, Berlingeri A et al. Evaluation of phenotypic and genotypic approaches for the detection of class A and class B carbapenemases in Enterobacteriaceae. Microb Drug Resist 2013; 19: 212-5
    • (2013) Microb Drug Resist , vol.19 , pp. 212-215
    • Ambretti, S.1    Gaibani, P.2    Berlingeri, A.3
  • 11
    • 84920154702 scopus 로고    scopus 로고
    • Genomic epidemiology of Klebsiella pneumoniae in Italy and novel insights into the origin and global evolution of its resistance to carbapenem antibiotics
    • Gaiarsa S, Comandatore F, Gaibani P et al. Genomic epidemiology of Klebsiella pneumoniae in Italy and novel insights into the origin and global evolution of its resistance to carbapenem antibiotics. Antimicrob Agents Chemother 59: 389-96
    • Antimicrob Agents Chemother , vol.59 , pp. 389-396
    • Gaiarsa, S.1    Comandatore, F.2    Gaibani, P.3
  • 12
    • 84965190732 scopus 로고    scopus 로고
    • The Harvest suite for rapid coregenome alignment and visualization of thousands of intraspecific microbial genomes
    • Treangen TJ, Ondov BD, Koren S et al. The Harvest suite for rapid coregenome alignment and visualization of thousands of intraspecific microbial genomes. GenomeBiol 2014; 15: 524
    • (2014) GenomeBiol , vol.15 , pp. 524
    • Treangen, T.J.1    Ondov, B.D.2    Koren, S.3
  • 13
    • 84891776599 scopus 로고    scopus 로고
    • PATRIC, the bacterial bioinformatics database and analysis resource
    • Wattam AR, Abraham D, Dalay O et al. PATRIC, the bacterial bioinformatics database and analysis resource. Nucleic Acids Res 2014; 42: D581-91
    • (2014) Nucleic Acids Res , vol.42 , pp. D581-D591
    • Wattam, A.R.1    Abraham, D.2    Dalay, O.3
  • 14
    • 84949194114 scopus 로고    scopus 로고
    • Within patient microevolution of Mycobacterium tuberculosis correlates with heterogeneous responses to treatment
    • Liu Q, Via LE, Luo T et al.Within patient microevolution of Mycobacterium tuberculosis correlates with heterogeneous responses to treatment. Sci Rep 2015; 5: 17507
    • (2015) Sci Rep , vol.5 , pp. 17507
    • Liu, Q.1    Via, L.E.2    Luo, T.3
  • 15
    • 84875578097 scopus 로고    scopus 로고
    • Using Tablet for visual exploration of second-generation sequencing data
    • Milne I, Stephen G, Bayer M et al. Using Tablet for visual exploration of second-generation sequencing data. Brief Bioinform 2013; 14: 193-202
    • (2013) Brief Bioinform , vol.14 , pp. 193-202
    • Milne, I.1    Stephen, G.2    Bayer, M.3
  • 16
    • 84871227763 scopus 로고    scopus 로고
    • LoFreq: a sequence-quality aware, ultrasensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets
    • Wilm A, Aw PP, Bertrand D et al. LoFreq: a sequence-quality aware, ultrasensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res 2012; 40: 11189-201
    • (2012) Nucleic Acids Res , vol.40 , pp. 11189-11201
    • Wilm, A.1    Aw, P.P.2    Bertrand, D.3
  • 17
    • 84995380111 scopus 로고    scopus 로고
    • Genomic characterization of colistin heteroresistance in Klebsiella pneumoniae during a nosocomial outbreak
    • Halaby T, Kucukkose E, Janssen AB et al. Genomic characterization of colistin heteroresistance in Klebsiella pneumoniae during a nosocomial outbreak. Antimicrob Agents Chemother 2016; 60: 6837-43
    • (2016) Antimicrob Agents Chemother , vol.60 , pp. 6837-6843
    • Halaby, T.1    Kucukkose, E.2    Janssen, A.B.3
  • 18
    • 84933531045 scopus 로고    scopus 로고
    • Impact of a hospital-widemultifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy
    • Viale P, Tumietto F, Giannella M et al. Impact of a hospital-widemultifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy. Clin Microbiol Infect 2015; 21: 242-7
    • (2015) Clin Microbiol Infect , vol.21 , pp. 242-247
    • Viale, P.1    Tumietto, F.2    Giannella, M.3
  • 19
    • 85018185416 scopus 로고    scopus 로고
    • In vitro selection of meropenem resistance among ceftazidime-avibactam-resistant, meropenem-susceptible Klebsiella pneumoniae isolates with variant KPC-3 carbapenemases
    • Shields RK, Nguyen MH, Press EG et al. In vitro selection of meropenem resistance among ceftazidime-avibactam-resistant, meropenem-susceptible Klebsiella pneumoniae isolates with variant KPC-3 carbapenemases. Antimicrob Agents Chemother 2017; 61: e00079-17
    • (2017) Antimicrob Agents Chemother , vol.61
    • Shields, R.K.1    Nguyen, M.H.2    Press, E.G.3
  • 20
    • 85030534150 scopus 로고    scopus 로고
    • Klebsiella pneumoniae (ST1519) producing KPC-19 carbapenemase in a patient undergoing selective digestive decontamination before liver transplant
    • Centonze AR, Azzini AM, Mazzi R et al. Klebsiella pneumoniae (ST1519) producing KPC-19 carbapenemase in a patient undergoing selective digestive decontamination before liver transplant. Clin Microbiol Infect 2018; 24: 203-4
    • (2018) Clin Microbiol Infect , vol.24 , pp. 203-204
    • Centonze, A.R.1    Azzini, A.M.2    Mazzi, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.